Surveillance endomyocardial biopsy in the modern era produces low diagnostic yield for cardiac allograft rejection

Transplantation

Volumn 99, Issue 8, 2015, Pages e75-e80

  Shah, Keyur B ^a   Flattery, Maureen P ^a   Smallfield, Melissa C ^a   Merinar, Grace ^a   Tang, Daniel G ^a   Sheldon, Emily H ^a   Thacker, Leroy R ^a   Kasirajan, Vigneshwar ^a   Cooke, Richard H ^a   Hess, Michael L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY MODERN PERIOD; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADVERSE EFFECTS; BIOPSY; EPIDEMIOLOGY; GRAFT REJECTION; HEART MUSCLE; IMMUNOLOGY; KAPLAN MEIER METHOD; MORTALITY; ODDS RATIO; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES;

IMMUNOSUPPRESSIVE AGENT;

ADULT; BIOPSY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIUM; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VIRGINIA;

EID: 84942417819     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000615     Document Type: Article

References (15)

1. Lower RR, Kontos HA, Kosek JC, Sewell DH, Graham WH. Experiences in heart transplantation. Technic, physiology and rejection. Am J Cardiol. 1968;22:766.
2. John R, Rajasinghe HA, Chen JM, et al. Long-termoutcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg. 2001;72:440.
3. Marboe CC, Billingham M, Eisen H, et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant. 2005;24:S219.
4. Stehlik J, Starling RC, Movsesian MA, et al. Utility of long-termsurveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant. 2006;25:1402.
5. Hamour IM, Burke MM, Bell AD, Panicker MG, Banerjee R, Banner NR. Limited utility of endomyocardial biopsy in the first year after heart transplantation. Transplantation. 2008;85:969.
6. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011. J Heart Lung Transplant. 2011; 30:1078.
7. Ensley RD, Bristow MR, Olsen SL, et al. The use of mycophenolatemofetil (RS-61443) in human heart transplant recipients. Transplantation. 1993; 56:75.
8. Kobashigawa J, Miller L, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation. 1998;66:507.
9. Grimm M, Rinaldi M, Yonan NA, et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients-a large European trial. Am J Transplant. 2006;6:1387.
10. Higgins R, Kirklin JK, Brown RN, et al. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy? J Heart Lung Transplant. 2005;24:392.
11. Aliabadi A, Grömmer M, Zuckermann A. Is induction therapy still needed in heart transplantation? Curr Opin Organ Transplant. 2011;16:536.
12. Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914.
13. Orrego CM, Cordero-Reyes AM, Estep JD, Loebe M, Torre-Amione G. Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation. J Heart Lung Transplant. 2012;31:845.
14. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010; 362:1890.
15. Mehra MR, Parameshwar J. Gene expression profiling and cardiac allograft rejection monitoring: Is IMAGE just a mirage? J Heart Lung Transplant. 2010;29:599.